Book Online or Call 1-855-SAUSALITO
Sign In \| Register \| About Sausalito \| Contact Us
Sausalito, CA September 01, 2020 1:41pm 7-Day Forecast \| Traffic

- Apartments

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Virtus Biotech Clinical Trials ETF (NY:BBC)

43.52 -0.94 (-2.11%)

Streaming Delayed Price Updated: 2:48 PM EDT, Apr 10, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	15,153
Open	44.76
Bid (Size)	43.52 (300)
Ask (Size)	43.61 (300)
Prev. Close	44.46
Today's Range	43.23 - 44.76
52wk Range	13.42 - 44.46
Shares Outstanding	4,000
Dividend Yield	1.51%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Why Did NGNE Stock Surge 25% In Pre-Market Today? ↗

February 27, 2026

The company said that the U.S. Food and Drug Administration granted a key designation for its investigational gene therapy targeting Rett syndrome.

Via Stocktwits

Why Did UPB Stock Pop 20% In Pre-Market Today? ↗

February 11, 2026

The company announced positive top-line results from its Phase 2 VALIANT trial evaluating Verekitug in adults with severe asthma.

Via Stocktwits

Performance

YTD	+15.7%	+15.7%
1 Month	+0.4%	+0.4%
3 Month	+11.4%	+11.4%
6 Month	+46.8%	+46.8%
1 Year	+184.8%	+184.8%

More News

ABUS Stock On Track For Biggest Intraday Drop In Over 5 Years – What’s The Issue Around Its Patent In Europe? ↗

January 16, 2026

Via Stocktwits

GLUE Stock Slips Pre-Market After Pricing $300 Million Public Offer At Discount ↗

January 09, 2026

Via Stocktwits

Why Did GLUE Stock Surge Over 50% In Premarket Today? ↗

January 07, 2026

Via Stocktwits

Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation ↗

May 07, 2025

Via Benzinga

ETFs Last Week: Funds Lead The Charge As Markets Stage A Return To Risk-On ↗

April 28, 2025

Via Benzinga

CureVac Stock Declines On Weaker-Than-Expected Q4 Revenue: Retail’s On Wait-And-Watch Mode ↗

April 10, 2025

Via Stocktwits

Why Is uniQure Stock Skyrocketing On Tuesday? ↗

December 10, 2024

Via Benzinga

Inflation Cools In June, Triggers Spike In Laggard ETFs ↗

July 12, 2024

Via Talk Markets

5 ETFs Riding High On The Biotech Comeback ↗

July 09, 2022

Via Talk Markets

Biotech ETF Tops in June: 5 Stocks That Outperform ↗

June 30, 2022

Via Talk Markets

4 Sector ETFs That Survived Market Turmoil in June ↗

June 29, 2022

Via Talk Markets

Frequently Asked Questions

Is Virtus Biotech Clinical Trials ETF publicly traded?

Yes, Virtus Biotech Clinical Trials ETF is publicly traded.

What exchange does Virtus Biotech Clinical Trials ETF trade on?

Virtus Biotech Clinical Trials ETF trades on the New York Stock Exchange

What is the ticker symbol for Virtus Biotech Clinical Trials ETF?

The ticker symbol for Virtus Biotech Clinical Trials ETF is BBC on the New York Stock Exchange

What is the current price of Virtus Biotech Clinical Trials ETF?

The current price of Virtus Biotech Clinical Trials ETF is 43.52

When was Virtus Biotech Clinical Trials ETF last traded?

The last trade of Virtus Biotech Clinical Trials ETF was at 04/10/26 02:48 PM ET

What is the market capitalization of Virtus Biotech Clinical Trials ETF?

The market capitalization of Virtus Biotech Clinical Trials ETF is 174.08K

How many shares of Virtus Biotech Clinical Trials ETF are outstanding?

Virtus Biotech Clinical Trials ETF has 174K shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Search Hotels in Sausalito

Find A Business

or Browse Listings

Virtus Biotech Clinical Trials ETF (NY:BBC)

Price and Volume

Top News

Performance

More News

Frequently Asked Questions